Cellular Microbiology

Cover image for Vol. 18 Issue 9

Edited By: Feng Shao (Editor-in-Chief), Neil Gow, Sergio Grinstein, Elizabeth Hartland (Reviews Editor), Jacomine Krijnse Locker, Artur Scherf, Thierry Soldati, Co-Founding Editors: Philippe Sansonetti and Richard S. Stephens

Impact Factor: 4.46

ISI Journal Citation Reports © Ranking: 2015: 21/123 (Microbiology); 56/187 (Cell Biology)

Online ISSN: 1462-5822

Associated Title(s): Molecular Microbiology

Editorial Board


Philippe Sansonetti
Richard S. Stephens


Feng Shao


National Institute of Biological Sciences (NIBS), No. 7 Science Park Road, Zhongguancun Life Science Park, Beijing 102206, China

Email: shaofeng@nibs.ac.cn
Tel: 86 10 807266888560
Fax: 86 10 80728046

Feng Shao

Feng Shao is an investigator and deputy director at National Institute of Biological Sciences (NIBS), Beijing, CHINA. He was a chemistry undergraduate of Peking University from 1991 to 1996 and received his master degree from Institute of Biophysics, Chinese Academy of Sciences in 1999. Dr. Shao was trained as a biochemist and obtained his PhD degree with Dr. Jack E. Dixon from University of Michigan in 2003. Prior to returning to China in 2005 to assume an assistant investigator and group leader position at NIBS, he was a Damon Runyon Postdoc Research Fellow at Harvard Medical School. Dr. Shao was promoted to be an associate investigator in 2009 and a full investigator in 2012 at NIBS. Dr. Shao’s research focuses on biochemical mechanism of bacterial infection and host innate immune defence. His laboratory has discovered several novel post-translational modifications used by the bacteria to block host defence as well as several cytosolic innate immune receptors/sensors for key bacterial molecules and toxins.

Neil Gow

School of Medical Sciences, Institute of Medical Sciences, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZD, United Kingdom

Email: n.gow@abdn.ac.uk

Neil Gow

Neil Gow is a microbiologist and medical mycologist who trained at Edinburgh University before doing at PhD Aberdeen University and a research fellowship in Denver, before returning to Aberdeen as a faculty member in 1984. He is a founding member of the Aberdeen Fungal Group which is one of the largest specialist centres in medical mycology. He is Director of Research and Commercialisation for the College of Life Sciences and Medicine at the University of Aberdeen in Scotland and he helps direct a Wellcome Trust Strategic Award to coordinate research and training activity in the field of medical mycology and fungal immunology across the UK and in developing countries. His research has been focussed on the molecular genetics of cell wall biosynthesis in pathogenic fungi; morphogenesis directional growth responses of fungal cells; the virulence and immunology of fungal infections and the evolution, genome biology and genotyping of Candida species.

Elizabeth Hartland (Reviews Editor)

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, 792 Elizabeth Street, Melbourne 3000, Victoria, Australia

Email: hartland@unimelb.edu.au
Tel: +61 3 8344 8041
Fax: +61 3 9347 1540

Elizabeth Hartland

Elizabeth Hartland completed her undergraduate studies in biochemistry and microbiology and obtained her PhD in 1996 from the University of Melbourne. She held a post-doctoral Royal Society/NHMRC Howard Florey Fellowship in the Department of Biochemistry, Imperial College London from 1998-2000 and Lecturer/Senior Lecturer positions in the Department of Microbiology, Monash University, Australia from 2000-2007. She returned to the University of Melbourne in 2007 where she was awarded an inaugural Australian Research Council Future Fellowship. She is the founder and convenor of the Victorian Infection and Immunity Network and is currently Professor of Microbiology and Head of the Department of Microbiology and Immunology at the University of Melbourne. Professor Hartland has a long-standing research interest in the pathogenesis of infections caused by Escherichia coli and Legionella, with a focus on mechanisms of bacterial colonization and immune evasion. Her research is particularly directed towards understanding the biochemical function of translocated bacterial effector proteins during infection.

Jacomine Krijnse Locker

Department of Infectious Diseases, Virology & Electron Microscopy Core Facility Im Neuenheimer Feld 324, 69120 Heidelberg, Germany

Email: jacomine.krijnse@bioquant.uni-heidelberg.de

Jacomine Krijnse Locker

Jacomine Krijnse Locker is a group-leader in cellular virology and co-heads the EM core facility at the university of Heidelberg, Germany. She obtained her PhD in Utrecht, the Netherlands, in 1994 on cellular aspects of coronaviruses. She then joined the European Molecular Biology Laboratory in Heidelberg where she worked on the cell biology of poxviruses, using state of the art imaging methods, in particular EM. In 2007 she joined the Heidelberg University where her own research interest focuses on the assembly of large DNA viruses. Using electron tomography and cryo-EM her group discovered that these viruses use an unconventional membrane assembly pathway and build up a membrane from open membrane intermediates derived from rupture of the ER. Within the EM facility her focus is to support EM projects that study cell-virus interactions using correlative light- and electron microscopy.

Artur Scherf

Biology of Host-Parasite Interactions Unit, URA2581, 25 Rue du Docteur Roux, F-75724 Paris Cedex 15, France

Email: ascherf@pasteur.fr
Tel: 33 (01) 4568-8616
Fax: 33 (01) 4568-8348

Artur Scherf

Artur Scherf is a biologist by training and received his PhD in 1987 from the University of Cologne, Germany working in the laboratory of Prof. Müller-Hill on the expression of vaccine candidates of the malaria parasite Plasmodium falciparum. Following a post-doctoral position working on genome plasticity of P. falciparum at the Institute Pasteur, Paris, he obtained a tenured CNRS position in 1989. Currently, he is professor at the Institute Pasteur where he heads the laboratory Biology of Host-Parasite Interactions and is Director of a CNRS unit on parasitology. His main research interests are the molecular and cellular mechanisms of P. falciparum immune evasion, the study of epigenetic factors that control virulence gene family expression and antigenic variation. He is also interested in developing new drugs that target key epigenetic regulators of malaria parasites.

Sergio Grinstein

The Hospital for Sick Children Research Institute, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada

Email: sergio.grinstein@sickkids.ca

Sergio Grinstein

Sergio Grinstein completed his Ph.D. in 1976 at the Centro de Investigacion, in Mexico City. He then spent two years as a post-doctoral fellow at the Hospital For Sick Children in Toronto, followed by a year in the Department of Biochemistry at the Federal Institute of Technology in Zurich. He is currently working at the Hospital For Sick Children in Toronto, where he was Head of the Programme in Cell Biology from 1987-2007 and has been Professor of Biochemistry at the University of Toronto since 1988. Sergio is interested in the interaction between bacterial pathogens and their host cells, particularly those of the innate immune system. He investigates the mechanisms of bacterial entry into the cells and the determinants of their intracellular fate.

Thierry Soldati

Department of Biochemistry, Sciences II, 30 Quai Ernest-Ansermet, 1211 Geneva 4, Switzerland

Email: thierry.soldati@unige.ch
Tel: 1(0)22 3796496
Fax: 1(0)22 3796470

Thierry Soldati

Thierry Soldati has been Associate Professor at the Department of Biochemistry, University of Geneva, since 2004. He carried out his doctoral work at the ETH in Zurich, studying the principles of cytoskeleton and cell architecture, and was then a postdoctoral fellow at Stanford University Medical School, unraveling the biochemical and cellular biology of endosomal protein trafficking. In 1995, he joined the Max Planck Institute for Medical Research in Heidelberg, as a group leader, focusing on the cooperation of signalling, cytoskeleton and membrane trafficking in phagocytosis, using the amoeba Dictyostelium as a model system. In 2001, he was appointed Lecturer at the Department of Biological Sciences of Imperial College London, where his group established this system to study host-pathogen interactions, and especially infection and dissemination of pathogenic Mycobacterium marinum. Recently, they have validated the use of the amoeba infection system for the medium-throughput screening for anti-infective compounds.


Richard S. Stephens (Co-Founding Editor)

Division of Infectious Diseases, 16 Barker Hall, University of California, Berkeley, CA 94720-7354, USA

Email: cmicro@berkeley.edu
Fax: 1 510 643 1537

Richard Stephens

Richard S. Stephens, Ph.D., is a Professor and Chair of the Infectious Disease Program at the University of California, Berkeley. He is a founder of Cellular Microbiology and has served as an Editor since its inception. He is an American Association for the Advancement of Science Fellow and an American Academy of Microbiology Fellow. His research interests concern pathogenic mechanisms of biological agents that cause infectious disease. The primary focus of this research is to understand the basis of immunity, pathogenesis, and virulence of the obligate intracellular pathogen Chlamydia.


Andrea Lewis
9600 Garsington Road
Oxford OX4 2DQ
Email: cell-micro-editorial-office@wiley.com


Laura Symul


Klaus Aktories, Albert-Ludwigs-Universität, Germany

Steffen Backert, University Erlangen, Germany

Philippe Bastin, Institut Pasteur, France

Roberto Botelho, Ryerson University, Canada

John Brumell, Hospital for Sick Children, Canada

Chetan Chitnis, International Centre for Genetic Engineering & Biotechnology, India

Maria Colombo, Universidad Nacional de Cuyo, Argentina

Brendan Cormack, Johns Hopkins University School of Medicine, USA

Pascale Cossart, Institut Pasteur, France

Christoph Dehio, University of Basel, Switzerland

Maurizio Del Poeta, Stony Brook University, USA

Michel Desjardins, Universite de Montreal, Canada

Tamara Doering, Washington University School of Medicine, USA

Guillaume Dumenil, INSERM, Paris, France

Joanne Engel, University of California, USA

Joel Ernst, New York University School of Medicine, USA

Greg Fairn, University of Toronto, Canada

Brett Finlay, University of British Columbia, Canada

Teresa Frisan, Karolinska Institute, Sweden

Martin Fraunholz, University of Würzburg, Germany

Freddy Frischknecht, Heidelberg University, Germany

Jean Pierre Gorvel, Aix Marseille Université, France

Urs Greber, University of Zurich, Switzerland

Nancy Guillen, Institute Pasteur, France

Maximiliano Gutierrez, The Francis Crick Institute, London, UK

Ted Hackstadt, Rocky Mountain Laboratories, USA

Volker Heussler, University of Bern, Switzerland

Hubert Hilbi, University of Zürich, Switzerland

David Holden, Imperial College London, UK

Bernard Hube, Hans-Knoell-Institute Jena, Germany

Ralph Isberg, Tufts University School of Medicine, USA

Jean-Paul Latge, Institut Pasteur, France

Bruno Lemaitre, EPFL, Switzerland

Elena Levashina, CNRS, Strasbourg, France

Stephan Ludwig, ZMBE, Muenster, Germany

Jason Mackenzie, University of Melbourne, Australia

Stéphane Meresse, CIML, France

Thomas Meyer, Max Planck Institute for Infection Biology, Germany

Cesare Montecucco, University of Padova, Italy

Maria Mota, Unidade de Malária, Portugal

Jeremy Mottram, University of Glasgow, Scotland, UK

Olivier Neyrolles, CNRS, Neyrolles, France

Guy Palmer, Washington State University, USA

Vincent Piguet, Cardiff University, Cardiff, UK

Daniel Portnoy, University of California, USA

Lalita Ramakrishnan, University of Washington, USA

Rino Rappuoli, Novartis Vaccines & Diagnostics Research, Italy

Felix Rey, Institut Pasteur, France

Cristina Risco, CNB-CSIC, Spain

Ilan Rosenshine, Hebrew University, Israel

Craig Roy, Yale University School of Medicine, USA

David Russell, Cornell University, USA

David Sacks, NIAID, NIH, USA

Philippe Sansonetti, Institut Pasteur, France

Mario Schelhaas, University of Münster, Germany

Sergio Schenkman, Universidade Federal de São Paulo, Brazil

Louis Schofield, The Walter and Eliza Hall Institute of Medical Research, Australia

William Shafer, Emory University School of Medicine, USA

David Sibley, Washington University, USA

Beate Sodeik, Hannover Medical School, Germany

Dominique Soldati-Favre, University of Geneva, Switzerland

Boris Striepen, University of Georgia, USA

Joel Swanson, University of Michigan, USA

Emily Troemel, University of California, San Diego, USA

Gisou van der Goot, EPFL, Lausanne, Switzerland

Michael Way, Cancer Research UK, London, United Kingdom

Tamotsu Yoshimori, Osaka University, Osaka, Japan

Arturo Zychlinsky, Max-Planck-Institute for Infection Biology, Berlin, Germany